Cargando…

Cell therapy in end-stage liver disease: replace and remodel

Liver disease is prevalent worldwide. When it reaches the end stage, mortality rises to 50% or more. Although liver transplantation has emerged as the most efficient treatment for end-stage liver disease, its application has been limited by the scarcity of donor livers. The lack of acceptable donor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Xin-Hao, Chen, Lan, Wu, Hao, Tang, Yang-Bo, Zheng, Qiu-Min, Wei, Xu-Yong, Wei, Qiang, Huang, Qi, Chen, Jian, Xu, Xiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210428/ https://www.ncbi.nlm.nih.gov/pubmed/37231461 http://dx.doi.org/10.1186/s13287-023-03370-z

Ejemplares similares

Remodeling the model for end‐stage liver disease for predicting mortality risk in critically ill patients with cirrhosis and acute kidney injury
por: Zhou, Xiao‐Dong, et al.
Publicado: (2017)

Stem cell transplantation for the treatment of end-stage liver disease
por: Wu, Dong-Bo, et al.
Publicado: (2018)

Prognostic Value of Modified Model for End-Stage Liver Disease Score in Patients Undergoing Isolated Tricuspid Valve Replacement
por: Xu, Hongjie, et al.
Publicado: (2022)

Modified model for end-stage liver disease improves short-term prognosis of hepatitis B virus-related acute-on-chronic liver failure
por: Chen, Wei, et al.
Publicado: (2017)

Development of a Novel Prognostic Nomogram for High Model for End-Stage Liver Disease Score Recipients Following Deceased Donor Liver Transplantation
por: Yang, Mengfan, et al.
Publicado: (2022)

Prevalence and associations of sarcopenia, obesity and sarcopenic obesity in end-stage knee osteoarthritis patients
por: Liao, Junyi, et al.
Publicado: (2023)

TREM2 as a Prognostic Biomarker for Osteosarcoma Microenvironment Remodeling
por: Shen, Zhi-Long, et al.
Publicado: (2023)

Outcomes of ABO-incompatible liver transplantation in end-stage liver disease patients co-infected with hepatitis B and human immunodeficiency virus
por: Tang, Jian-Xin, et al.
Publicado: (2023)

Type-specific dysregulation of matrix metalloproteinases and their tissue inhibitors in end-stage heart failure patients: relationship between MMP-10 and LV remodelling
por: Wei, Yingjie, et al.
Publicado: (2011)

Right Heart Remodeling in Patients with End-Stage Alcoholic Liver Cirrhosis: Speckle Tracking Point of View
por: Zhang, Kun, et al.
Publicado: (2019)

Hypertriglyceridemia Causing Continuous Renal Replacement Therapy Dysfunction in a Patient with End-stage Liver Disease
por: McLaughlin, D. C., et al.
Publicado: (2018)

Recent trends in the incidence and survival of stage I liver cancer: a surveillance, epidemiology, and end results analysis
por: Yu, Xue-Chen, et al.
Publicado: (2022)

Clinical application of stem cell in patients with end-stage liver disease: progress and challenges
por: Tao, Ya-Chao, et al.
Publicado: (2020)

Albumin for End-Stage Liver Disease
por: Lee, June Sung
Publicado: (2012)

Adult stem cell transplantation combined with conventional therapy for the treatment of end-stage liver disease: a systematic review and meta-analysis
por: Zhu, Chen-Hui, et al.
Publicado: (2021)

Prognostic performance of a series of model for end-stage liver disease and respective Δ scores in patients with hepatitis B acute-on-chronic liver failure
por: XUN, YUN-HAO, et al.
Publicado: (2014)

Model for End‐Stage Liver Disease/Pediatric End‐Stage Liver Disease exception policy and outcomes in pediatric patients with hepatopulmonary syndrome requiring liver transplantation
por: Raza, Muhammad H., et al.
Publicado: (2023)

Trends of Mortality in End-Stage Liver Disease — China, 2008–2020
por: Wang, Xiaoxiao, et al.
Publicado: (2023)

Prospective, single-centre, randomised controlled trial to evaluate the efficacy and safety of ischaemia-free liver transplantation (IFLT) in the treatment of end-stage liver disease
por: Huang, Changjun, et al.
Publicado: (2020)

Fu brick tea alleviates high fat induced non-alcoholic fatty liver disease by remodeling the gut microbiota and liver metabolism
por: Tang, Yan, et al.
Publicado: (2022)

Outcome of Using Small-For-Size Grafts in Living Donor Liver Transplantation Recipients with High Model for End-Stage Liver Disease Scores: A Single Center Experience
por: Li, HongYu, et al.
Publicado: (2013)

Total Ankle Replacement for Treatment of End-Stage Osteoarthritis in Elderly Patients
por: Hintermann, Beat, et al.
Publicado: (2012)

End-Stage Renal Disease and Renal Replacement Therapy in older Patients
por: Smyth, Andrew
Publicado: (2012)

Renal replacement therapy in Latin American end-stage renal disease
por: Rosa-Diez, Guillermo, et al.
Publicado: (2014)

Pretransplant Prediction of Posttransplant Survival for Liver Recipients with Benign End-Stage Liver Diseases: A Nonlinear Model
por: Zhang, Ming, et al.
Publicado: (2012)

A novel remnant liver-first strategy for liver autotransplantation in patients with end-stage hepatic alveolar echinococcosis: a retrospective case series
por: Lv, Tao, et al.
Publicado: (2023)

Staged replacement of both hips and both knees in patients with rheumatoid arthritis
por: Cao, Jian, et al.
Publicado: (2023)

Collateral circulation caused by end-stage hepatic alveolar echinococcosis
por: Jiang, Tiemin, et al.
Publicado: (2023)

Transplantation of Autologous Mesenchymal Stem Cells for End-Stage Liver Cirrhosis: A Meta-Analysis Based on Seven Controlled Trials
por: Ma, Xiang-Rui, et al.
Publicado: (2015)

The therapeutic effect of Rosuvastatin on cardiac remodelling from hypertrophy to fibrosis during the end-stage hypertension in rats
por: Zhang, WB, et al.
Publicado: (2012)

Long-term cardiac remodeling associated with heart failure following left-ventricular valve replacement surgery: A retrospective study
por: Chen, Mengyuan, et al.
Publicado: (2021)

The Model for End-stage Liver Disease 3.0 is not superior to the Model for End-stage Liver Disease-Na in predicting survival: A retrospective cohort study
por: Duan, Fangfang, et al.
Publicado: (2023)

Opportunistic infections in end stage liver disease
por: Bartoletti, Michele, et al.
Publicado: (2018)

Chronotropic incompetence in end-stage liver disease
por: Główczyńska, Renata, et al.
Publicado: (2022)

Deletion of Microfibrillar‐Associated Protein 4 Attenuates Left Ventricular Remodeling and Dysfunction in Heart Failure
por: Wang, Hui-bo, et al.
Publicado: (2020)

Liver Regeneration and Cell Transplantation for End-Stage Liver Disease
por: Li, Yan, et al.
Publicado: (2021)

Altered brain activity in end‐stage knee osteoarthritis revealed by resting‐state functional magnetic resonance imaging
por: Kang, Bing‐Xin, et al.
Publicado: (2021)

Knee arthrodesis using a unilateral external fixator combined with crossed cannulated screws for the treatment of end-stage tuberculosis of the knee
por: Tang, Xin, et al.
Publicado: (2015)

End-stage liver disease score and future liver remnant volume predict post-hepatectomy liver failure in hepatocellular carcinoma
por: Kong, Fan-Hua, et al.
Publicado: (2019)

Prognostic Value of Model for End-Stage Liver Disease Incorporating with Serum Sodium Score for Development of Acute Kidney Injury after Liver Transplantation
por: Cheng, Yuan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5tkrt3g5rnc09l3g7cim1t42mb